<?xml version='1.0' encoding='UTF-8'?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-03-10T06:42:59Z</responseDate>
  <request metadataPrefix="oai_dc" identifier="oai:ir.soken.ac.jp:00001377" verb="GetRecord">https://ir.soken.ac.jp/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:ir.soken.ac.jp:00001377</identifier>
        <datestamp>2023-06-20T14:44:28Z</datestamp>
        <setSpec>2:430:27</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns="http://www.w3.org/2001/XMLSchema" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>CBF-1 Controls the Retinotectal Topographic Map along the Anteroposterior Axis through Multiple Mechanisms</dc:title>
          <dc:title>CBF-1 Controls the Retinotectal Topographic Map along the Anteroposterior Axis through Multiple Mechanisms</dc:title>
          <dc:creator>高橋, 弘雄</dc:creator>
          <dc:creator>タカハシ, ヒロオ</dc:creator>
          <dc:creator>TAKAHASHI, Hiroo</dc:creator>
          <dc:description>総合研究大学院大学</dc:description>
          <dc:description>博士（理学）</dc:description>
          <dc:description>Topographic maps with a defined spatial ordering of neuronal connections are a key feature of the brain's organization.  The most widely used model for studies of the formation of topographic maps is the retinotectal projection.  Chick brain factor-1 (CBF-1), a nasal retina-specific winged-helix transcription factor, is known to prescribe the nasal specificity which leads to the formation of the precise retinotectal map especially along the antero-posterior (A-P) axis.  However, the molecular mechanisms by which CBF-1 controls the expression of topographic molecules have not been elucidated.  In the present study, to gain insight into the downstream target genes of CBF-1, he employed electroporation of a retroviral vector carrying the CBF-1 gene into the optic vesicle, and examined effects of the misexpression of CBF-1 on the expression of topographic molecules and other asymmetrically distributed molecules.  The in ovo electroporation of retrovirus allows the immediate and sustained expression of a transgene.  Since endogenous CBF-1 begins to be topographically expressed prior to Hamburger-Hamilton (HH) stage 11 in native embryos, at which stage the polarity along the nasotemporal (N-T) axis appears to be determined, this in ovo electroporation system is suitable for the functional study of CBF-1.  Here, he shows that ectopic expression of CBF-1 in the temporal retina represses expression of EphA3 and CBF-2, and induces that of SOHo-1, GH6, ephrin-A2, and ephrin-A5.  A chimeric protein that consists of an even-skipped repression domain and CBF-1 DNA binding domain exerted the same effects as the wild-type CBF-1 on the expression of S0Ho-1, GH6, EphA3, CBF-2, and ephrin-AS, but not on that of ephrin-A2.  On the other hand, a CBF-1 mutant deficient in DNA-binding activity exerted the same effects as the wild-type CBF-1 on the expression of S0Ho-1, GH6, EphA3, CBF-2, and ephrin-AX, but not ephrin-AS.  These results suggest that CBF-1 controls ephrin-A5 by a DNA binding-dependent mechanism, ephrin-A2 by a DNA binding-independent mechanism, and CBF-2, SOHo-1, GH6, and EphA3 by dual mechanisms.&lt;br /&gt;  Our lab recently identified a novel secreted molecule, Ventroptin, which is an antagonist of bone morphogenetic protein 4 (BMP-4) in the retina, and demonstrated that Ventroptin is implicated in the retinotectal topographic projection along both the dorsoventral (D-V) and A-P axes.  Asymmetrical expression of Ventroptin along the N-T axis regulates the graded expression of ephrin-A2 along this axis but not of ephrin-A5 or EphA3 in the retina, which is associated with the retinotectal mapping along the A-P axis.  Vneroptin expression is ventral-specific, complementary to the dorsal-specific BMP-4 expression at the early developmental stage of the retina.  However, along with a decline of BMP-4 expression from the dorsal retina, the expression of Ventroptin forms a double-gradient pattern along the two axes from E6.  This suggests that a member of the TGF-□ family other thin BMP-4 should appear in a temporal high-nasal low gradient along the N-T axis with a complementary pattern to the Ventroptin expression.  In this study, he found that a TGF-□ family member, BMP-2, is expressed in a pattern complementary to that of Ventroptin, with a double-gradient along the two axes from E6 onward.  Ventroptin antagonizes BMP-2 as well as BMP-4.  Misexpression of BMP-2 in the developing retina repressed expression of Ventroptin and ephrin-A2.  Moreover, he demonstrates that CBF-1 perturbs BMP-2 signaling through a DNA binding-independent mechanism, which resultantly causes the induction of ephrin-A2 expression.  These results thus suggest that CBF-1 is located at the top of the gene cascade for the regional specification along the N-T axis in the retina and distinct BMP signals play pivotal roles in the topographic projection along both axes.</dc:description>
          <dc:description>application/pdf</dc:description>
          <dc:description>総研大甲第725号</dc:description>
          <dc:description>thesis</dc:description>
          <dc:date>2003-09-30</dc:date>
          <dc:format>application/pdf</dc:format>
          <dc:format>application/pdf</dc:format>
          <dc:identifier>https://ir.soken.ac.jp/record/1377/files/甲725_要旨.pdf</dc:identifier>
          <dc:identifier>https://ir.soken.ac.jp/record/1377/files/甲725_本文.pdf</dc:identifier>
          <dc:identifier>https://ir.soken.ac.jp/records/1377</dc:identifier>
          <dc:language>eng</dc:language>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
